Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Drone Delivery Canada (FLT-X) says it plans to collaborate with Toyota Tsusho Canada Inc., a division of the Toyota Group of companies, on a drone delivery logistics platform. “This agreement with TTCI is expected to open international markets for us as a company,” stated Tony Di Benedetto, CEO of Drone Delivery Canada, in a release. “Working alongside a global industrial leader such as Toyota Tsusho also provides us quick access to a very extensive international global network and a breadth of commercial skills.”

**

Story continues below advertisement

Newstrike Resources Ltd. (HIP-X) reported net income of $ 3.1-million or a penny per share in the first quarter ended March 31. It cited the receipt of the $9.5-million termination fee from CanniMed Therapeutics Inc. after a canceled takeover offer and a favorable revaluation of biological assets of $896,920 that helped it generate non-operating revenue of $10.5-million. That compared to a loss of $7.6-million or 4 cents per share a year earlier, when it had no revenue.

**

Quarterhill Inc. (QTRH-T; QTRH-Q) says a subsidiary has acquired a portfolio of patents from Panasonic Corp. including 34 patent families comprising 96 patents worldwide. “The portfolio relates to security camera surveillance technologies covering image analysis, image recognition, camera control, camera mechanical/housing technologies; and security camera systems used in retail and other commercial buildings as well as in smart home applications,” the company said. The terms of the agreement are confidential.

**

MedReleaf Corp. (LEAF-T) says it has an agreement with BioPharma Services Inc. to conduct clinical research for cannabis and cannabis-derived products. Under the agreement BioPharma will become an extension of MedReleaf’s clinic development team.

**

CannaRoyalty Corp. (CRZ-CN) reported revenues of $643,437 in the first quarter ended March 31 as compared to $301,111 a year ago. Its net loss of $4.7-million or 10 cents per share compared to $2.1-million or 5 cents a year ago. The adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) loss per share of was 5 cents as compared to 4 cents a year ago.

Story continues below advertisement

**

MPX Bioceutical Corp. (MPX-CN) says it has completed a US$40-million secured convertible loan. “The proceeds of the offering will be used primarily for accretive activities including capacity expansion, acquisitions, and to support activities involved with securing new cannabis extraction, production and dispensary licenses in various jurisdictions in both the United States and Canada,” the company stated.

**

Emerald Health Therapeutics Inc. (EMH-X) reported revenue of $373,218 in the first quarter ended March 31 versus $201,268 a year ago. Its net loss was $5-million or 4 cents per share versus a loss of $1.2-million or 2 cents a year ago.

**

Emblem Corp. (EMC-X) says it generated $1.3-million in revenue in the first quarter compared to $903,000 for the same period a year ago. Its net loss was $3.8-million or 3 cents per share versus a loss of $2.5-million or 4 cents a year earlier.

Story continues below advertisement

**

Sunniva Inc. (SNN-CN) says it received a “confirmation of readiness” from Health Canada for a licence under the Access to Cannabis for Medical Purposes Regulations for its Sunniva Medical Inc. subsidiary. “This represents acceptance of our detailed application with the next step being an inspection upon site readiness in order to commence cultivation,” the company stated.

**

Maverix Metals Inc. (MMX-X) says it’s buying a ”significant portfolio” of 54 royalties from Newmont Mining Corp. and its affiliates. Maverix will issue to Newmont a total of 60 million common shares and 10 million common share purchase warrants and make a cash payment of US$17-million upon closing of the transaction. It said the warrants will be exercisable for five years from the date the transaction closes at a price of US$1.64 per common share.

**

Labrador Iron Ore Royalty Corp. (LIF-T) says USW Locals 5795 and 6731 in Labrador City have voted to accept the offer presented by The Iron Ore Company of Canada.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter